Arizona Uloric Injury Lawyer

Uloric, also called febuxostat, is a prescription drug used to lower uric acid in adults with gout, and it carries an FDA Black Box Warning tied to increased risk of heart related harm. People who suffer a serious cardiac event after taking Uloric can face major medical costs, time away from work, and lasting health effects or worse. Understanding the warning history, reported cardiovascular risks, and how liability is evaluated can help clarify what happened. If you or a loved one were harmed or worse due to Uloric drug injuries in Arizona, contact Hastings Law Firm for a free, confidential case review.

A hand holds a Febuxostat prescription bottle over a legal document, illustrating the need for an Arizona Febuxostat Injury lawyer.

Trusted Legal Representation for Uloric Drug Injuries in Arizona

What You Should Know About Febuxostat Injury Claims in Arizona:

  • Severe cardiovascular outcomes can follow Uloric use, including heart attack and stroke.
  • The FDA added a Black Box Warning to Uloric after safety trials showed a higher risk of heart related death compared to allopurinol.
  • A wrongful death claim may be considered when a loved one dies after a Uloric related cardiac event.
  • Legal options can be lost entirely if Arizona filing deadlines are missed.
  • Liability disputes often focus on whether Takeda Pharmaceuticals knew of cardiovascular risks yet failed to adequately warn doctors and patients.
  • Compensation can include medical bills, lost wages, pain and suffering, and wrongful death damages for surviving family members.
  • Many Uloric lawsuits proceed as individual cases that are consolidated into Multi District Litigation rather than a class action.
  • Proof issues can turn on prescription records, hospital records of the cardiac event, and documentation of financial losses.
  • Causation is often addressed through expert testimony linking febuxostat to the injury.
An interior view of the best medical malpractice law firm in Arizona
FREE CASE EVALUATION 877-269-4620 NO FEE UNLESS WE WIN (HABLAMOS ESPAÑOL)

A Healthcare Focused Law Firm

If you or someone you love suffered a serious heart event after taking Uloric, you may be dealing with far more than a medical setback. You may be facing mounting hospital bills, lost time at work, and difficult questions about whether this could have been prevented. These concerns are valid, and you deserve clear answers about what happened and what your legal options are.

At Hastings Law Firm, we focus exclusively on medical malpractice and pharmaceutical injury cases. Our team includes in-house medical professionals and former defense attorneys who understand how drug manufacturers and their insurers respond to these claims. As a firm of experienced Arizona Uloric injury lawyers, we are prepared to review the facts of your situation, explain your rights, and help you determine the best path forward.

Contact us for a free, confidential case evaluation. You pay nothing unless we recover compensation on your behalf.

Understanding the FDA Black Box Warning and Uloric Risks

The FDA added a Black Box Warning to Uloric (febuxostat), a prescription medication used to lower uric acid levels in adults with gout, after safety trials revealed a significantly higher risk of heart-related death compared to allopurinol. This Black Box Warning, the most serious safety alert the FDA can place on a drug’s label, signals that the medication carries risks of severe or life-threatening adverse effects.

Manufactured by Takeda Pharmaceuticals, Uloric was approved in 2009. Post-approval safety data analyzed by a Phoenix Uloric lawyer revealed alarming results. According to the U.S. Food and Drug Administration’s safety communication on Uloric (febuxostat), patients taking febuxostat had a higher rate of death from heart-related causes than those on allopurinol.

A detailed review published in Reassessing the Cardiovascular Safety of Febuxostat (PubMed Central) reinforces these concerns. Febuxostat litigation attorneys note that the ULORIC febuxostat prescribing label (FDA) now reflects this updated warning.

If you experienced a cardiac event, an Arizona defective drug lawyer at our firm can evaluate your case. Patients across Arizona are now working with a Uloric lawsuit attorney to hold Takeda accountable for injuries that may have been preventable.

Warning signs that a Uloric attorney in Arizona suggests monitoring include:

  • Chest pain or tightness
  • Shortness of breath
  • Rapid or irregular heartbeat
  • Sudden dizziness or fainting
  • Swelling in the legs (possible sign of blood clots)
Comparison chart explaining the FDA Black Box Warning and key safety differences between Uloric febuxostat and allopurinol for an Arizona Uloric Injury Lawyer search.

Recognizing Uloric Injuries and Cardiovascular Events

Patients taking Uloric may experience severe cardiovascular injuries, including heart attack, stroke, unstable angina (a type of chest pain caused by reduced blood flow to the heart), and cardiac death due to the drug’s mechanism of action, a risk febuxostat attorneys take seriously. Families who lost a loved one after Uloric use may also have grounds for a wrongful death lawsuit with the help of Arizona Uloric claim counsel.

The connection between febuxostat and these events is grounded in clinical data from large-scale safety trials. If you or a family member experienced any of the following symptoms while taking Uloric, speak with both a cardiologist and a Uloric injury attorney in Arizona.

SymptomPotential Condition
Chest pain or pressureHeart attack or unstable angina
Sudden numbness or confusionStroke
Shortness of breathPulmonary embolism (PE), a blood clot in the lungs
Leg swelling or painDeep vein thrombosis (DVT), a blood clot in a deep vein
Rapid or irregular heartbeatCardiac arrhythmia
Sudden dizziness or collapseCardiac event or stroke

Patients may suffer a pulmonary embolism (PE), a blockage of blood flow to the lungs, or deep vein thrombosis (DVT), a clot formation in a deep vein that can travel to the lungs. Both conditions have been reported in patients using febuxostat, a fact noted by dangerous drug attorneys.

For families grieving a loved one’s death following Uloric use, a febuxostat lawyer in Arizona can help determine whether a wrongful death claim is appropriate based on the medical timeline, a task for our Uloric injury legal team.

Statistical Risks of Cardiac Death

The FDA’s Black Box Warning was prompted by the CARES trial, or Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities, which followed over 6,000 gout patients with pre-existing cardiovascular conditions.

The CARES trial measured major adverse cardiovascular events (MACE), a standard composite endpoint that includes heart attack, stroke, cardiovascular death, and unstable angina requiring urgent intervention. While the overall MACE rates were similar between the two drugs, the rate of heart-related death and all-cause death was notably higher in the febuxostat group.

These findings show a statistical increase in risk central to Uloric injury claims. An Arizona Uloric injury lawyer can use this data, alongside your medical records and prescribing history, to help establish whether febuxostat contributed to your cardiac event.

Warning checklist of cardiovascular red flags such as chest pain shortness of breath and stroke symptoms relevant to Uloric users for an Arizona Uloric Injury Lawyer query.

The Hastings Law Firm Difference

Results matter, but what truly sets us apart is how we achieve them. Every verdict, every settlement, and every Arizona courtroom victory comes from one guiding promise: To treat each client’s fight for justice as if it were our own.

  • 20+ years of exclusive focus on healthcare litigation, allowing our entire practice to understand this complex field.
  • Board-certified trial leadership under Tommy Hastings, ensuring every case is approached with precision and integrity.
  • In-house medical professionals including nurse paralegals and certified patient advocates.
  • National network of medical experts who provide the specialized testimony needed to prove complex claims.
  • Proven multimillion-dollar verdicts and settlements that demonstrate meaningful outcomes.
  • Compassionate, client-centered representation that ensures each person feels respected and supported.

This balance of skill, experience, and empathy reflects our core philosophy that justice should not only compensate the injured, but also make healthcare safer nationwide.

Personal injury trial attorney Tommy Hastings in a suit standing outside of a courtroom before a medical litigation case starts.

How to Establish Liability for a Uloric Claim in Arizona

Establishing liability requires proving that Takeda Pharmaceuticals knew of the cardiovascular risks yet failed to adequately warn doctors and patients in Arizona, directly resulting in the injury. This legal theory, “failure to warn,” occurs when a manufacturer does not provide enough information about a drug’s risks. It is common in dangerous drug lawsuits. While manufacturers may raise defenses, an Arizona Uloric lawyer can help manage these claims.

Under Arizona product liability law, a product liability lawyer notes that a drug manufacturer can be held liable if its product was defective due to inadequate warnings. Arizona law requires that product liability actions be commenced within the time period prescribed by Arizona Revised Statutes § 12-551 (Arizona Legislature). In a Uloric claim, this means showing that Takeda had access to safety data, including results from clinical research conducted after a drug reaches the market, and provided insufficient warnings.

An Arizona pharmaceutical liability lawyer at Hastings Law Firm builds your case by gathering records and working with medical experts, including our in-house nurse practitioners, to establish the link between febuxostat and the injury.

If liability is established, compensation for a Uloric injury may include:

  • Past and future medical bills related to the cardiac event
  • Lost wages and diminished earning capacity
  • Pain and suffering and other non-economic damages
  • Wrongful death damages for surviving family members

Compensation may also cover unstable angina, a condition involving chest pain due to reduced blood flow. Many Uloric lawsuits are handled as individual cases consolidated into Multi-District Litigation (MDL), a process where many similar cases are grouped together for efficiency while preserving your individual claim. A Uloric claims attorney can explain which structure applies, and Arizona dangerous drug lawyers can review your specific losses.

Process flowchart showing how an Arizona Uloric Injury Lawyer proves failure to warn liability from Uloric use to cardiovascular event causation evidence and damages.

Contact the Arizona Dangerous Drug Attorneys at Hastings Law Firm Today for Help

Arizona imposes strict deadlines on when you can file a pharmaceutical injury or wrongful death claim. Waiting too long can mean losing your right to seek compensation entirely, so acting promptly matters.

Founded by board-certified trial lawyer Tommy Hastings, an ABOTA member who has practiced for over 20 years, our firm is dedicated to securing accountability for patients harmed by medical and pharmaceutical negligence. Hastings Law Firm represents Uloric injury clients throughout Arizona from our Phoenix office. Our legal and medical team will review your records, evaluate the strength of your claim, and explain every option available to you.

We work on a contingency fee basis, which means you pay no attorney fees or costs unless we secure a recovery on your behalf. If you or a loved one suffered a heart attack, stroke, or other cardiac event after taking Uloric, we are ready to listen and help you understand your next steps. Call us today or complete our online form for a free, confidential case evaluation.

Frequently Asked Questions About Uloric Injury in Arizona

Eligibility typically includes patients who were prescribed Uloric (febuxostat) for gout and then suffered a cardiovascular event, such as a heart attack, stroke, or unstable angina. Families who lost a loved one to a Uloric-related cardiac event may also file a wrongful death claim.

In Arizona, the statute of limitations for product liability or personal injury claims is generally two years from the date of the injury or discovery of the harm. This is known as the discovery rule, which means the clock starts when you first learn of the injury or its cause.

Determining settlement ranges depends on compensation factors like economic damages, medical bills, lost income, and the impact on quality of life. Cases involving wrongful death or permanent cardiac damage typically result in higher compensation.

To prove a claim, you need prescription proof showing Uloric use, hospital records of the cardiac event, and documentation of financial losses. Expert testimony often establishes causation linking the drug and the injury.

Most dangerous drug cases are handled as an individual lawsuit consolidated into a mass tort or MDL (Multi-District Litigation), rather than a class action. This ensures you receive compensation based on your specific injuries rather than a split share among all participants.

A group photo of the staff at Hastings Law Firm Medical Malpractice Lawyers
Have a Question? Our Team of Board Certified Patient Advocates, Nurse Paralegals, and Experienced Trial Attorneys are Here to Answer Your Questions.

Key Uloric Injury Terms:

Febuxostat (Uloric)
A prescription medication used to treat gout by lowering uric acid levels in the blood. Febuxostat is the generic name, and Uloric is the brand name manufactured by Takeda Pharmaceuticals. In the context of injury claims, this drug has been linked to increased risks of cardiovascular death and other serious heart-related events.
Boxed Warning (Black Box Warning)
The most serious type of warning that the U.S. Food and Drug Administration (FDA) can require on a prescription drug label. It appears in a box with a bold border to alert doctors and patients about potentially life-threatening risks. In a medical malpractice or product liability case, the presence of a black box warning is important because it shows the manufacturer knew about serious dangers and had a duty to clearly communicate them.
CARES trial (Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Morbidities)
A major clinical study comparing the heart safety of febuxostat (Uloric) to allopurinol in gout patients who already had cardiovascular disease. The trial found that patients taking Uloric had a higher rate of death from heart-related causes than those taking allopurinol. This study is often central to proving that the manufacturer knew or should have known about the increased cardiovascular risks.
Major adverse cardiovascular events (MACE)
A medical term used in clinical trials to describe serious heart-related problems, including heart attack, stroke, and cardiovascular death. In Uloric injury cases, MACE is used to measure and compare the frequency of life-threatening heart events between patients taking different gout medications.
Deep vein thrombosis (DVT)
A blood clot that forms in a deep vein, usually in the legs. DVT can cause pain, swelling, and redness, and is dangerous because the clot can break loose and travel to the lungs. In the context of Uloric injuries, DVT is one of the cardiovascular events that may be associated with the medication and should have been disclosed to patients and doctors.
Pulmonary embolism (PE)
A blockage in one of the arteries in the lungs, usually caused by a blood clot that travels from the legs or other parts of the body. Symptoms include sudden shortness of breath, chest pain, and rapid heartbeat. PE is a life-threatening emergency and is one of the serious cardiovascular events linked to Uloric use that may form the basis of an injury claim.
Unstable angina
A type of chest pain caused by reduced blood flow to the heart that occurs unpredictably, even at rest, and does not follow a stable pattern. It is considered a medical emergency because it often signals that a heart attack may occur soon. In a Uloric liability case, unstable angina may be evidence of cardiovascular harm that the drug manufacturer failed to adequately warn about.
Post-marketing study
Research conducted after a drug has been approved and is being sold to the public, designed to monitor its safety and effectiveness in a larger, more diverse patient population over a longer period. In product liability cases, post-marketing studies like the CARES trial are critical because they can reveal serious risks that were not detected in earlier, smaller clinical trials, and may show that the manufacturer had knowledge of dangers after the drug was already on the market.

Get Answers Today

If you think that medical negligence, a dangerous drug, or a failed medical product caused harm to you or someone you love, our team is standing by to offer guidance. We’ll explain your options under current laws and help you move forward with clarity and understanding. Case reviews are free and 100% confidential.